Evidence map›Paper›PMID 33792282›Full record

ArticleAccounts of chemical research2021

Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics.

Lingchao Cai, Ian B Seiple, Qi Li

Open access · greenAbstract read
In one paragraph

Article in Accounts of chemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Complete Genome Sequencing ofMicroorganisms · 2025
    Article
  3. Article
  4. Identification of four novelInternational journal of systematic and evolutionary microbiology · 2025
    Article
  5. Review
  6. Review
  7. Treatment of MRSA Infection: Where are We?Current medicinal chemistry · 2024
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Lingchao CaiJiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jiangsu Key Lab of Biomass-Based Green Fuels and Chemicals, Nanjing Forestry University, Nanjing 210037, Jiangsu China.
Ian B SeipleDepartment of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-8732-1362
Qi LiShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Chinese Academy of Sciences · CNNanjing Forestry University · CNUniversity of California, San Francisco · US

Funding

Platforms for the Synthesis of Bacterial Protein Synthesis InhibitorsR35GM128656 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SEIPLE, IAN BASS · 2018 to 2022
$2.1M
NIGMS NIH HHS R35 GM128656
6 · The paper itself

Abstract

Continued, rapid development of antimicrobial resistance has become worldwide health crisis and a burden on the global economy. Decisive and comprehensive action is required to slow down the spread of antibiotic resistance, including increased investment in antibiotic discovery, sustainable policies that provide returns on investment for newly launched antibiotics, and public education to reduce the overusage of antibiotics, especially in livestock and agriculture. Without significant changes in the current antibiotic pipeline, we are in danger of entering a post-antibiotic era.In this Account, we summarize our recent efforts to develop next-generation streptogramin and lankacidin antibiotics that overcome bacterial resistance by means of modular chemical synthesis. First, we describe our highly modular, scalable route to four natural group A streptogramins antibiotics in 6-8 steps from seven simple chemical building blocks. We next describe the application of this route to the synthesis of a novel library of streptogramin antibiotics informed by in vitro and in vivo biological evaluation and high-resolution cryo-electron microscopy. One lead compound showed excellent inhibitory activity in vitro and in vivo against a longstanding streptogramin-resistance mechanism, virginiamycin acetyltransferase. Our results demonstrate that the combination of rational design and modular chemical synthesis can revitalize classes of antibiotics that are limited by naturally arising resistance mechanisms.Second, we recount our modular approaches toward lankacidin antibiotics. Lankacidins are a group of polyketide natural products with activity against several strains of Gram-positive bacteria but have not been deployed as therapeutics due to their chemical instability. We describe a route to several diastereomers of 2,18-

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliGram-Negative BacteriaGram-Positive BacteriaMacrolidesMicrobial Sensitivity TestsMolecular ConformationMolecular Dynamics SimulationRibosomesStreptograminsVirginiamycinAnti-Bacterial AgentslankacidinsMacrolidesStreptograminsVirginiamycinvirginiamycin M2

Identifiers

PMID33792282
PMCPMC8214311
OpenAlexW3149125421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.